{
  "functional_evidence_assessment": {
    "variant_id": {
      "Gene": "A30P",
      "Protein_Change": {
        "ref": "L",
        "alt": "P",
        "position": "30"
      },
      "variant_string_id": "A30P_L_P"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The causes and mechanisms for the degeneration of dopaminergic neurons and formation of Lewy bodies are unknown.",
        "judgment": "Yes",
        "reasoning": "Paper defines the disease mechanism as Lewy bodies and Dopaminergic neuron loss."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "Microarrays were used to investigate transcriptional changes.",
        "judgment": "Yes",
        "reasoning": "Gene expression assays model the molecular mechanism."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays.",
        "extracted_paper_info": "Selected genes were confirmed by quantitative RT-PCR.",
        "judgment": "Yes",
        "reasoning": "Controls (qRT-PCR) validate the assay."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation.",
        "extracted_paper_info": "No direct OddsPath calculation or statistical tests for pathogenicity were mentioned.",
        "judgment": "N/A",
        "reasoning": "Insufficient data on controls and statistics."
      }
    ],
    "final_evidence_strength": {
      "type": "PS3_supporting",
      "value": 2.0
    },
    "e evidence_step4": {
      "statistical_tests": "No OddsPath calculated, variant controls unclear."
    }
  }
}